$34,880,933

Department of Health and Human Services·Office of Assistant Secretary for Preparedness and Response

WORK BEGAN2026-04-01·LATEST ACTION2026-04-01·SOURCEUSASPENDING·SOURCE IDCONT_AWD_75A50126C00002_7505_-NONE-_-NONE-

Award description

NON SURGICAL DEBRIDEMENT

Verbatim from USAspending.gov. Capitalization, abbreviations, and codes are unchanged.

The Buildout's read

What the model surfaced from this award

Confidence: medium

In plain English

Supply Vericel's non-surgical debridement products—cellular therapies for wound care—for national emergency medical preparedness.

Sub-sectors

wound-caremedical-countermeasuresemergency-preparedness

Why this matters

Establishes strategic supply of advanced wound-care therapeutics; critical for disaster response and medical resilience.

Supply-chain signal

Ensures steady-state manufacturing capacity for complex biotherapeutics; strengthens domestic supply for emergency response.

U.S.–China competition angle

Invests in US domestic medical product manufacturing; reflects focus on medical supply chain independence.

Generated by award_classification v2.1.0 via claude-haiku-4-5-20251001 on 2026-06-16. Cost: $0.020148.

Period of performance

Start

2026-04-01

End

2036-03-31

Status

activein 3547 days

Recipient

Sources

USAspending.gov — all awards for this UEI →
SAM.gov entity registration →
Award record ingested from usaspending. Source identifier CONT_AWD_75A50126C00002_7505_-NONE-_-NONE-.

The Buildout does not edit federal records. Any inaccuracy reflects the upstream source; it will update here when corrected there.